GH Research (GHRS) Other Non Operating Income (2021 - 2025)

GH Research (GHRS) recorded quarterly Other Non Operating Income of -$140000.0 in Q4 2025, down 105.5% quarter-over-quarter from $2.5 million in Q3 2025, and up 93.6% on a YoY basis from -$72314.6 in Q4 2024.

GH Research (GHRS) Other Non Operating Income (2021 - 2025) Analysis & Trends

GH Research's Other Non Operating Income history runs 5 years deep, the most recent figure standing at -$140000.0 for Q4 2025.

  • In Q4 2025, Other Non Operating Income rose 93.6% year-over-year to -$140000.0; the TTM figure through Dec 2025 stood at $6.8 million (up 239.7% YoY), while the FY2025 annual figure was -$1.8 million, up 17.66% from the prior year.
  • Other Non Operating Income was -$140000.0 for Q4 2025 at GH Research, down from $2.5 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $22.7 million in Q4 2022 to a low of -$8.3 million in Q4 2023.
  • Historically, Other Non Operating Income has averaged $1.9 million across 5 years, with a median of $1.2 million in 2021.
  • Biggest YoY gain for Other Non Operating Income was 1178.7% in 2022; the steepest drop was 24822.22% in 2022.
  • A 5-year view of Other Non Operating Income shows it stood at $2.5 million in 2021, then surged by 797.71% to $22.7 million in 2022, then slumped by 136.76% to -$8.3 million in 2023, then surged by 73.8% to -$2.2 million in 2024, then surged by 93.6% to -$140000.0 in 2025.
  • The last three Other Non Operating Income figures came in at -$140000.0 (Q4 2025), $2.5 million (Q3 2025), and $2.5 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn -
7 Psyence Biomedical 241.78 Bn 241.78 Bn -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn
9 Abivax 94.26 Bn 94.26 Bn -
10 GH Research 9.73 Bn 9.63 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -140,000.00
Sep 30, 2025 2.55 Mn
Jun 30, 2025 2.50 Mn
Mar 31, 2025 1.92 Mn
Dec 31, 2024 -2.19 Mn
Sep 30, 2024 -1.85 Mn
Jun 30, 2024 466,000.00
Mar 31, 2024 -1.32 Mn
Dec 31, 2023 -8.35 Mn
Sep 30, 2023 4.07 Mn
Jun 30, 2023 2.20 Mn
Mar 31, 2023 -1.64 Mn
Dec 31, 2022 22.71 Mn
Sep 30, 2022 6.19 Mn
Jun 30, 2022 7.08 Mn
Mar 31, 2022 -2.24 Mn
Dec 31, 2021 2.53 Mn
Sep 30, 2021 2.83 Mn
Jun 30, 2021 554,000.00
Mar 31, 2021 -9,000.00